Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-25T03:35:40.068Z Has data issue: false hasContentIssue false

Naxolone in Amylobarbitoneresponsive Catatonia

Published online by Cambridge University Press:  29 January 2018

Maurice W. Dysken
Affiliation:
Department of Psychiatry, University of Chicago, Chicago, Illinois 60637, U.S.A.
John M. Davis
Affiliation:
Department of Psychiatry, University of Chicago, Chicago, Illinois 60637, U.S.A.
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1978 

References

Bloom, F., Segal, D., Ling, N. & Guillemin, R. (1976) Endorphins: profound behavioural effects in rats suggest new etiological factors in mental illness. Science, 194, 630–2.Google Scholar
Casey, J. F., Bennett, I. F., Lindley, C. J., Hollister, L. E., Gordon, M. H. & Springer, N. N. (1960) Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. Archives of General Psychiatry, 2, 210–20.Google Scholar
Costall, B. & Naylor, R. J. (1973) Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forschung, 23, 674–83.Google Scholar
Dysken, M. W., Kooser, J. A., Haraszti, J. S. & Davis, J. M. (1978 in press) Clinical usefulness of sodium amobarbital interviewing. Archives of General Psychiatry. CrossRefGoogle Scholar
Elkes, J. (1957) Effects of psychosomimetic drugs in animals and man, in Abramson, H. A. (ed.): Neuropharmacology: Transactions of the Third Conference, Josiah Macy, Jr. Foundation, pp 205–95.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.